Statistical analysis
The prevalence of tocilizumab off-label use was calculated by the number of off-label prescribed patients divided by the total number of tocilizumab used patients. Additionally, the proportion of each off-label indication among the total off-label prescriptions was also analyzed. Finally, we compared how different professional titles affect off-label use of tocilizumab prescribing with analysis of logistic regression.